Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
The leading three animal health distributors in the US could be facing more of a challenge from smaller competitors as their market share dipped in the last year.
Slovenian pharmaceutical company Krka has seen its animal health sales remain stable over 2017 with 1% year-on-year growth.
In this latest podcast, Animal Pharm editor Joseph Harvey speaks to Scott Brown, vice president of external innovation at Zoetis. The podcast below covers the company's blueprint for external collaboration, particularly with human health businesses.
Purdue University has formally opened its new $60 million animal sciences complex in the US.
Zoetis has confirmed its plans to expand its global manufacturing and supply facility in Charles City, Iowa.
A new bill has been introduced in the New York State of Assembly to enable veterinarians to prescribe medical marijuana for pets.
Earlier this month, animal health companies and human biotechnology specialists converged on a blizzard-hit Boston to seek potential cross-industry partnerships. Animal Pharm editor Joseph Harvey attended to sample the climate for collaboration between the two sectors.
The US animal health industry is an "integral part of the US economy" worth around $9.9 billion in revenues, according to a new report from the Animal Health Institute (AHI).
US lawmakers have urged the US FDA to expand its conditional approval process for animal drugs to help bring more critical veterinary medicines to market.
Stonehaven Incubate has been launched to translate innovation in the human health space into new animal health companies. Animal Pharm Joseph Harvey editor spoke to the firm's chief executive Mark Heffernan about this new home for start-ups.
US companion animal medicines firm Poïesis Therapeutics is now working on a pipeline of eight candidates in-licensed from human biotechnology companies.
The US FDA has issued draft guidance on proprietary names for new animal drugs.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.